Canlyniadau Chwilio - Stephanie Guidez

PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (... gan Benoit Tessoulin, Stephanie Guidez, Manjusha Namuduri, Ashish Risal3, Alpana Waldron, Nickolas A. Sophos, Amulya Uppala, Min Zhu, Siobhán Nolan, Jurriaan Brouwer-Visser, Aafia Chaudhry, Srikanth Ambati, Hesham Mohamed, David Tucker

Cael y testun llawn

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strate... gan Valentin Letailleur, Isabelle Chaillol, Fanny Cherblanc, Hervé Ghesquières, Frédéric Peyrade, Stéphanie Guidez, Fontanet Bijou, Pierre Sesques, Cédric Rossi, Luc-Matthieu Fornecker, Ludovic Fouillet, Sylvain Carras, Loïc Chartier, Aurélien Belot, Lucie Oberic, Fabrice Jardin, Benoit Tessoulin

Cael y testun llawn

Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA study gan Axel André, Estelle Bourbon, Guillaume Cartron, Franck Morschhauser, Amandine Fayard, Laure Ricard, Roberta Di Blasi, Adrien Chauchet, Stéphanie Guidez, Cristina Castilla-Llorente, Gabriel Brisou, Pierre Bories, Roch Houot, Anne Cuozzo, Elodie Gat, François Lemonnier, Camille Laurent

Cael y testun llawn

Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group gan Marion Aymard, Morgane Cheminant, Roch Houot, Anne Cuozzo, Elodie Gat, Catherine Thieblemont, Laure Ricard, Louise Roulin, Krimo Bouabdallah, Violaine Safar, Stéphanie Guidez, Amandine Fayard, Gabriel Brisou, Loic Ysebaert, Olivier Hermine, Benoît Tessoulin, Charles Herbaux, Steven Le Gouill, Clémentine Sarkozy

Cael y testun llawn

Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSAResear... gan Clémentine Sarkozy, Thierry Jo Molina, Sydney Dubois, Cédric Portugues, Elodie Bohers, Loic Ysebaert, Roch Houot, Gian Matteo Pica, Philippe Ruminy, Charles Herbaux, Thomas Gastinne, Catherine Thieblemont, Corinne Haioun, Stéphanie Guidez, Christophe Bonnet, Gilles Crochet, Liana Veresezan, Sylvain Choquet, Emmanuel Bachy, Fabrice Jardin, Franck Morschhauser, Vincent Ribrag

Cael y testun llawn

P1083: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 gan Michał Taszner, Stefano Luminari, Seok-Goo Cho, Silvana Novelli, Steven Le Gouill, Michelle Poon, Jose Villasboas, Rebecca Champion, Emmanuel Bachy, Stephanie Guidez, Aránzazu Alonso Alonso, Deepa Jagadeesh, Michele Merli, David Tucker, Jingxian Cai, Carolina Leite de Oliveira, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Tae Min Kim

Cael y testun llawn

Hairy cell leukemia with isolated bone lesions gan Laura Cailly, Cécile Gruchet, Elsa Maitre, Stephanie Guidez, Vincent Delwail, Thomas Systchenko, Niels Moya, Florence Sabirou, Anthony Levy, Arthur Bobin, Hélène Gardeney, Laly Nsiala, Mathilde Vonfeld, Aurélia Chacon, Aurélien Pichon, Sabrina Bouyer, Caroline Baslé, Elodie Dindinnaud, Jean‐Claude Chomel, Anna Raimbault, Florence Borde‐Mougenot, Xavier Troussard, Cécile Tomowiak

Cael y testun llawn

P1098: A PHASE II, OPEN-LABEL, MULTICENTER STUDY OF CAPIVASERTIB, A POTENT, ORAL PAN-AKT INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (CAPITAL) gan Daniel Hodson, Geoffrey Shouse, Ho-Jin Shin, Antonio Salar Silvestre, Sabela Bobillo Varela, Vincent Ribrag, Nicol Macpherson, Raul Cordoba, Jin Seok Kim, John Radford, Stephanie Guidez, Alex F. Herrera, Franck Morschhauser, Dachelle Johnson, Macarena Izuzquiza, Nisha Sambamurthy, Alessandra Forcina, Gullu Gorgun, Robert Chen, Anas Younes, Michael Wang, Wong Seog Kim

Cael y testun llawn

P1146: TRANSFUSION NEEDS AFTER CD19 CAR T-CELLS FOR LARGE B-CELL LYMPHOMA: PREDICTIVE FACTORS AND IMPACT ON OUTCOME. A DESCAR-T STUDY. gan Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, Guillaume Cartron, Thomas Gastinne, Ibrahim Yakoub-Agha, Fabien Le Bras, Kamal Bouabdallah, Fabien Despas, Jacques Olivier Bay, Marie-Thérèse Rubio, Mohamad Mohty, Rene Olivier Casasnovas, Sylvain Choquet, Cristina Castilla-Llorente, Stephanie Guidez, Michael Loschi, Blandine Guffroy, Sylvain Carras, Laurianne Drieu La Rochelle, Roch Houot

Cael y testun llawn

Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study gan Julien Lazarovici, Sandy Amorim, Krimo Bouabdallah, Marguerite Fournier, Stéphanie Guidez, Lysiane Molina, Franck Morschhauser, Baptiste Delapierre, Thomas Gastinne, Kamel Laribi, Vincent Launay, Bohrane Slama, Nawel Belmecheri, René-Olivier Casasnovas, Anne Corby, Eric Durot, Pierre Feugier, Emmanuelle Nicolas-Virelizie, David Sibon, Alina Berriolo-Riedinger, Véronique Edeline, Thierry Vander Borght, Diane Damotte, Alexandra Traverse-Glehen, Vincent Ribrag, Marc André

Cael y testun llawn

Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry gan Charles Herbaux, Caroline Bret, Emmanuel Bachy, Pierre Bories, Roberta Di Blasi, Alexis Cuffel, Thomas Gastinne, Thierry Lamy, Mikael Roussel, Krimo Bouabdallah, David Beauvais, Guillaume Cartron, Jacques-Olivier Bay, Didier Blaise, Marie-Therese Rubio, Mohamad Mohty, Fabien Le Bras, Olivier Casasnovas, Julien Guy, Stephanie Guidez, Cristina Castilla Llorente, Olivier Hermine, Laurianne Drieu La Rochelle, Sylvain Carras, Blandine Guffroy, Sophie Caillat-Zucman, Roch Houot, Steven Le Gouill

Cael y testun llawn

Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry gan Federico Erbella, Emmanuel Bachy, Guillaume Cartron, Elodie Gat, Guillaume Manson, Franck Morschhauser, Francois-Xavier Gros, Louise Roulin, Benoit Tessoulin, Pierre Bories, Olivier Tournilhac, Laure Ricard, Stéphanie Guidez, Sylvain Choquet, Rene-Olivier Casasnovas, Gabriel Brisou, Arnaud Campidelli, Cristina Castilla-Llorente, Fabrice Jardin, Emmanuel Gyan, Blandine Guffroy, Julie Abraham, Justine Decroocq, Adrien Chauchet, Magalie Joris, Fabien Claves, Sylvain Carras, Gaëlle Guillerm, Michaël Loschi, Olivier Hermine, Aline Taguy-Schimidt, Steven Le Gouill, Roch Houot, Roberta Di Blasi

Cael y testun llawn

Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group gan Pierre Sesques, Guillaume Manson, Guillaume Cartron, François‐Xavier Gros, Franck Morschhauser, Cristina Castilla‐Llorente, Gabriel Brisou, Pierre Bories, Catherine Thieblemont, Laurianne Drieu La Rochelle, Benoit Tessoulin, Axel André, Cedric Rossi, Jérôme Paillassa, Stephanie Guidez, Antoine Capes, Laura Herbreteau, Sylvain Choquet, Jacques‐Olivier Bay, Adrien Chauchet, Laure Lebras, Fabien Claves, Julie Abraham, Jean‐Valère Malfuson, Marie‐Thérèse Rubio, Justine Decroocq, Luc‐Matthieu Fornecker, Gandhi Damaj, Ludovic Fouillet, Magalie Joris, Michael Loschi, Olivier Hermine, Hadia Hafirassou, Emelie Van Zele, Vivien Dupont, Steven Le Gouill, Roch Houot, Vincent Camus

Cael y testun llawn

Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma gan Pierre Sesques, Amy A. Kirkwood, Mi Kwon, Kai Rejeski, Michael D. Jain, Roberta Di Blasi, Gabriel Brisou, François-Xavier Gros, Fabien le Bras, Pierre Bories, Sylvain Choquet, Marie-Thérèse Rubio, Gloria Iacoboni, Maeve O’Reilly, René-Olivier Casasnovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Julie Abraham, Cristina Castilla Llorente, Mickael Loschi, Sylvain Carras, Adrien Chauchet, Laurianne Drieu La Rochelle, Olivier Hermine, Stéphanie Guidez, Pascale Cony-Makhoul, Patrick Fogarty, Steven Le Gouill, Franck Morschhauser, Thomas Gastinne, Guillaume Cartron, Marion Subklewe, Frederick L. Locke, Robin Sanderson, Pere Barba, Roch Houot, Emmanuel Bachy

Cael y testun llawn

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study gan Olivier Tournilhac, Kamal Bouabdallah, Solène Lecolant, Maya Hacini, Kamel Laribi, Sébastien Bailly, Thibaut Belmondo, Marie Maerevoet, Loic Ysebaert, Stéphanie Guidez, Steven Le Gouill, Christophe Bonnet, Marc André, Jehan Dupuis, Catherine Thieblemont, Emmanuel Bachy, Nicolas Daguindau, Franck Morschhauser, Sabine Tricot, Charline Moulin, Anne Banos, Roch Houot, Adrien Chauchet, Emmanuel Gyan, Guillaume Cartron, Hassan Farhat, Vincent Camus, Bernard Drenou, Hacene Zerazhi, David Sibon, Emmanuelle Nicolas-Virelizier, Caroline Delette, Sylvia Snauwaert, Sarah Bailly, Richard Delarue, Sylvain Carras, Albane Ledoux-Pilon, Marie-Cécile Parrens, Samuel Griolet, Philippe Gaulard, Marie-Hélène Delfau-Larue, Laurence de Leval, Gandhi Laurent Damaj

Cael y testun llawn